S&P 500 Futures
(0.11%) 5 527.75 points
Dow Jones Futures
(0.17%) 39 535 points
Nasdaq Futures
(0.05%) 19 937 points
Oil
(0.48%) $81.93
Gas
(-1.15%) $2.57
Gold
(-0.02%) $2 339.10
Silver
(-0.24%) $29.49
Platinum
(-1.92%) $994.60
USD/EUR
(-0.33%) $0.930
USD/NOK
(-0.38%) $10.63
USD/GBP
(-0.20%) $0.789
USD/RUB
(1.35%) $86.88

Sanntidsoppdatering for Organicell Regenerative [OCEL]

Børs: OTC Sektor: Healthcare Industri: Biotechnology
Sist oppdatert4 mar 2024 @ 21:14

-0.27% $ 2.74

Live Chart Being Loaded With Signals

Commentary (4 mar 2024 @ 21:14):
Our systems believe the stock currently is undervalued by 0.24% compare to its pairs and should correct upwards.

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases...

Stats
Dagens volum 4 735
Gjennomsnittsvolum 4 716
Markedsverdi 19.97M
EPS $-0.150 ( Q4 | 2024-01-29 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.567
(Sector) 0
(Industry) 0
ATR14 $0 (0.00%)
ACUT 16.78%
AIMD -3.89%
AKABY 0.00%
AOBI 0.00%
ARNI 417.24%
BETRF 0.00%
BRAXF 7.14%
BVNRY -7.81%
CLVLY -2.39%
COEP 1.05%
CPMV 0.00%
CRXM 0.00%
CSLLY 0.20%
ERGO 0.00%
GSTC 0.00%
IPCIF 0.00%
LVCLY 0.00%
MLCT 2.63%
NPTX 0.00%
NUGX 0.00%
OBMP -37.10%
OCEL -0.27%
ODTC 0.00%
OTLC 6.45%
PFND 0.00%
PROT 0.00%
PVCT 1.11%
QSAM -99.95%
RGBP 10.45%
RGBPP 0.00%
RSPI 8.11%
SIGY 0.00%
SILO 1.01%
SKYE 10.33%
SNNAQ 0.00%
SPHRY 0.00%
UCBJY 0.39%
USRM 0.00%
VGLS 100.00%
VICP 59.29%
WXXWY -1.02%
Insider Trading
Date Person Action Amount type
2023-06-29 Leider Harry L. Buy 500 000 Common Stock
2023-06-28 Leider Harry L. Buy 549 450 Common Stock
2023-12-19 Leider Harry L. Sell 5 248 Common Stock
2023-07-07 Skycrest Holdings, Llc Buy 320 710 Common Stock
2023-06-29 Skycrest Holdings, Llc Buy 200 000 Common Stock
INSIDER POWER
-81.72
Last 93 transactions
Buy: 116 969 610 | Sell: 385 387 546
Korrelasjon (AI algo v.1.1b): Undervalued: 0.24% $2.76 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Organicell Regenerative Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Organicell Regenerative Økonomi

Annual 2023
Omsetning: $4.56M
Bruttogevinst: $4.05M (88.86 %)
EPS: $-0.990
FY 2023
Omsetning: $4.56M
Bruttogevinst: $4.05M (88.86 %)
EPS: $-0.990
FY 2022
Omsetning: $6.49M
Bruttogevinst: $5.74M (88.39 %)
EPS: $-1.570
FY 2021
Omsetning: $5.60M
Bruttogevinst: $5.05M (90.21 %)
EPS: $-0.0100

Financial Reports:

No articles found.

Organicell Regenerative Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Organicell Regenerative

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 1.0414819717407 seconds
Number of API calls: 3
Number of DB calls: 9